Tempest Therapeutics Shares Resume Trade
Portfolio Pulse from Benzinga Newsdesk
Shares of Tempest Therapeutics have resumed trading.
October 12, 2023 | 1:43 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Trading of shares for Tempest Therapeutics (TPST) has resumed.
The resumption of trading for a company's shares doesn't inherently indicate a positive or negative impact on the stock price. It simply means that the shares are again available for trading. The impact on the stock price will depend on the market's reaction to whatever caused the trading halt in the first place.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100